NCT07412431Not yet recruiting
Periodontal Health Profile in Multiple Sclerosis Patients
Evaluation of Periodontal Status in Patients With Multiple Sclerosis: A Clinical, Microbiological, and Biochemical Study
Source: ClinicalTrials.gov · Last updated 17 Feb 2026
Brief summary (registry, in English)
This study aims to evaluate the periodontal status of patients with Multiple Sclerosis (MS) through clinical, microbiological, and biochemical parameters. Multiple sclerosis and periodontal diseases are both chronic inflammatory conditions that may share common immunopathological pathways. The primary objective is to investigate the relationship between MS and periodontal health by comparing clinical measurements with the microbial composition and biochemical markers found in saliva samples of patients followed by the Neurology Department.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 3 Feb 2026
- Start date
- Feb 2026
- Primary completion date
- Oct 2026
- Lead sponsor
- Saglik Bilimleri Universitesi
- Diseases
- Multiple sclerosis
- NCT number
- NCT07412431
What you commit to
- Study type: Observational
- Planned participants: 100
- From Feb 2026 to the primary completion date, Oct 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Having received antibiotic treatment within the last 3 months.
- Having received periodontal treatment within the last 6 months.
- Patients undergoing radiotherapy or chemotherapy.
- Having received antibiotic treatment within the last 3 months.
- Having received periodontal treatment within the last 6 months.
- Patients undergoing radiotherapy or chemotherapy.
Age
- Being under 18 years of age.
- Being under 18 years of age.
Other
- Patients whose MS diagnosis is not yet definitive.
- Being pregnant or in the lactation (breastfeeding) period.
- Being diagnosed with Multiple Sclerosis (MS) according to the 2017 McDonald criteria.
- Being pregnant or in the lactation (breastfeeding) period.
Who the study is looking for
- Voluntarily agreeing to participate in the study.
- Being over 18 years of age.
- Diagnosed with Multiple Sclerosis (MS) according to the 2017 McDonald criteria.
- Being able to communicate clearly and effectively.
- Voluntarily agreeing to participate in the study.
- Being over 18 years of age.
- Not having a diagnosis of Multiple Sclerosis (MS) according to the 2017 McDonald criteria.
- Being able to communicate clearly and effectively.
Age in the registry: 18 years to 65 years · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.